Cyclic hypoxia does not alter RAD51 expression or PARP inhibitor cell kill in tumor cells

Ramya Kumareswaran, Naz Chaudary, Karolina Jaluba, Alice Meng, Jenna Sykes, Asm Borhan, Richard P. Hill, Robert G. Bristow

Research output: Contribution to journalArticlepeer-review

Abstract

Solid tumors contain regions of chronic and cyclic hypoxia. Chronic hypoxia can downregulate RAD51 and sensitize cells to PARP inhibition. Herein, we show that RAD51 expression, cell survival and toxicity to PARP inhibition is not affected under cyclic hypoxic conditions. This suggests that PARP inhibition may be selectively toxic in tumor sub-regions associated with chronic hypoxia.

Original languageEnglish
Pages (from-to)388-391
Number of pages4
JournalRadiotherapy and Oncology
Volume116
Issue number3
DOIs
Publication statusPublished - 1 Sept 2015

Keywords

  • Cyclic hypoxia
  • DNA repair
  • PARP inhibition
  • RAD51

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'Cyclic hypoxia does not alter RAD51 expression or PARP inhibitor cell kill in tumor cells'. Together they form a unique fingerprint.

Cite this